Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Eisai signs tropical disease deal

November 12, 2013 Research and Development, Sales and Marketing Disease, Eisai, Japan, broad, ntd, tropical

Eisai has become the latest pharma firm to partner with the US-based Broad Institute to pool expertise and come up …
News

NICE needs more Velcade data

November 12, 2013 Sales and Marketing NHS, NICE, Velcade, eric low

NICE has slowed the progress of Janssen Cilag’s Velcade towards becoming an NHS treatment for multiple myeloma by asking the …
News

Celgene hires new medical director

November 12, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, kilcoyne

Biopharma firm Celgene has announced the appointment of Dr Adrian Kilcoyne as its new medical director. He will take up …
Appointment

AstraZeneca ups cancer drug production at Alderley Park

November 11, 2013 Manufacturing and Production, Sales and Marketing AstraZeneca, Cancer, Zoladex, alderley park

AstraZeneca says it plans to invest around £120 million in a new cancer drug manufacturing facility at its plant in …
News

Sanofi to produce weight-loss drug for Orexigen

November 11, 2013 Manufacturing and Production, Sales and Marketing Contrave, FDA, Sanofi, orexigen

Sanofi has agreed a deal to manufacture Orexigen Therapeutics’ weight-loss candidate Contrave outside North America. Under the commercial supply agreement, …
News

Shire spends $4.2 billion on ViroPharma purchase

November 11, 2013 Sales and Marketing Cinryze, Firazyr, Shire, Viropharma

Shire has announced a $4.2 billion deal to buy US-based ViroPharma in a pact that is designed to bolster the …
News

Cancer Research backs ‘unique’ database

November 11, 2013 Research and Development, Sales and Marketing Cancer, Database, ICR, cansar

An oncology database – said to be the world’s largest in any disease area and funded by Cancer Research UK …
News

Novartis sheds blood diagnostics for $1.7 billion

November 11, 2013 Sales and Marketing Genoptix, Novartis, blood, grifols

Novartis has announced the sale of its blood transfusion diagnostics unit to the specialist Spanish firm Grifols for $1.67 billion.Headquartered …
News

‘Fatal’ safety concerns throw doubt on Lemtrada

November 11, 2013 Research and Development, Sales and Marketing FDA, Genzyme, Lemtrada, MS, Sanofi

An FDA committee has dashed hopes of an approval for Sanofi’s multiple sclerosis drug after saying its benefits may not …
News

The CDF: friend and foe?

November 11, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, CDF, Cancer, NICE, eric low

Few things in my professional life have troubled me more than the Cancer Drugs Fund (CDF) since its inception in …
Feature

New chief executive for the International Diabetes Federation

November 11, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing diabetes, petra wilson

The International Diabetes Federation (IDF) has appointed Dr Petra Wilson as its chief executive. Wilson joins IDF from Cisco, where …
Appointment

BMS abandons hep C, diabetes and neuroscience

November 11, 2013 Sales and Marketing BMS, HIV, diabetes, hep C

Bristol-Myers Squibb is admitting defeat in hepatitis C, diabetes and neuroscience and will abandon research in these areas in a …
News

Bayer submits Eylea in EU for DME

November 8, 2013 Sales and Marketing Bayer, DME, EMA, Eylea, FDA

Bayer HealthCare is seeking to extend the licence of its VEGF Trap-Eye, which is already marketed as Eylea in various …
News

EMA questions Brilinta data

November 8, 2013 Sales and Marketing Brilinta, EMA, astrazenca, heart, ticagrelor

The European Medicines Agency is demanding more information from AstraZeneca on its troubled heart pill Brilinta. This rounds off a …
News

Genticel appoints vice president



November 8, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing genticel, moeller

Biopharma firm Genticel has appointed Dr Gerald Moeller to sit on its supervisory Board as a vice president. Moeller has …
Appointment
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026